The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Can Mounjaro Help With Lipedema?
Lipedema is a chronic condition affecting fat distribution, causing pain and swelling in the legs and sometimes arms. While Mounjaro (tirzepatide) is not specifically approved for lipedema, some people with this condition combined with overweight or obesity may be considered for treatment through NHS specialist weight management services. Mounjaro is a prescription-only dual GIP and GLP-1 receptor agonist that may help manage overall weight, which can ease symptoms in some cases. Whether Mounjaro is appropriate requires individual assessment by your GP and specialist services. This guide explains the NHS context, eligibility criteria, and how to access support in the UK.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Lipedema and Weight Management in the NHS
Lipedema is distinct from obesity — it is a progressive condition involving abnormal fat distribution, typically in the legs and hips, accompanied by pain, swelling (oedema), and easy bruising. Many people with lipedema also experience excess weight, which can compound joint stress and mobility issues. The NHS recognises lipedema as a legitimate medical condition, though it is often underdiagnosed.
Mounjaro works as a dual GIP and GLP-1 receptor agonist, signalling to the brain that you feel full and slowing gastric emptying. While it is not approved specifically for lipedema, managing overall body weight alongside lipedema care may reduce pressure on affected limbs and potentially ease some associated discomfort. However, weight loss alone does not resolve lipedema — specialist care addressing the condition itself remains essential.
- Mounjaro is prescription-only and requires clinical assessment
- It is not a lipedema-specific treatment
- Weight reduction may ease secondary symptoms in some cases
- NHS access is through tier 3 specialist weight management services
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
NHS Access and Eligibility for Mounjaro
In the UK, Mounjaro is available through the NHS only via tier 3 specialist weight management services. These services assess whether prescription medication is appropriate based on your individual health profile. For someone with lipedema plus overweight or obesity, referral from your GP to a specialist service may be possible, though availability varies significantly by region and NHS Integrated Care Board.
To access NHS specialist services, start with your GP who can discuss your symptoms, assess your BMI, and refer you if appropriate. You may also explore private prescription routes through UK-licensed online prescribers, which do not require NHS referral. Use the BMI calculator on this page to understand your current health metrics, and discuss options with your GP as the first step.
- NHS route: GP referral to tier 3 specialist weight management services
- Regional waiting lists can be lengthy in many areas
- Private route: online clinical assessment with a UK-licensed prescriber
- Always inform prescribers about lipedema when seeking assessment
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is Mounjaro approved by NICE for lipedema treatment?
No. Mounjaro (tirzepatide) is NICE-approved and NHS-available for weight management in adults with a BMI of 30 or above, or 27–29.9 with weight-related comorbidities. Lipedema alone is not listed as a qualifying condition, though some individuals with both lipedema and obesity may be eligible for consideration through specialist services.
Can Mounjaro supports or treat lipedema directly?
No. Mounjaro is not a lipedema treatment. It is a weight management medication that may help reduce overall body weight, potentially easing secondary symptoms like joint pressure. Lipedema requires specialist assessment and care from services experienced in managing the condition itself, which may include compression, lymphatic drainage, and physiotherapy.
How do I access Mounjaro on the NHS if I have lipedema?
Start by discussing your symptoms and weight with your GP. If you have a BMI of 30 or above (or 27–29.9 with comorbidities), your GP may refer you to a tier 3 NHS specialist weight management service in your area. This service will assess whether Mounjaro is appropriate. Waiting times vary by region; some areas have significant delays.
What dose of Mounjaro would be used for lipedema and weight?
Mounjaro dosing is not lipedema-specific. Standard dosing starts at 2.5 mg weekly and escalates every 4 weeks up to a maximum of 15 mg weekly, depending on tolerance and response. Your prescriber will determine the appropriate dose for you based on your individual health, not your specific condition.
Should I mention my lipedema when seeking Mounjaro prescription?
Yes. Always inform your GP or prescriber about lipedema, as it is a relevant part of your medical history. Lipedema may affect how your prescriber assesses overall suitability for weight management treatment and what support you might need alongside medication.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.